Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Dec 14;32(12):E6–E10. doi: 10.1002/clc.20503

Neutrophil to Lymphocyte Ratio as a Predictor of Long‐term Mortality in African Americans Undergoing Percutaneous Coronary Intervention

Shyam Poludasu 1, Erdal Cavusoglu 1, Waqas Khan 1, Jonathan D Marmur 1,
PMCID: PMC6653698  PMID: 20014207

Abstract

Background

Neutrophil to lymphocyte ratio (N/L ratio) has been shown to predict long‐term mortality in patients undergoing percutaneous coronary intervention (PCI). African Americans have been shown to have lower mean neutrophil counts compared to whites. The usefulness of the N/L ratio in predicting long‐term mortality in African Americans undergoing PCI is unknown.

Methods

We evaluated a total of 372 African American patients (327 patients with lower N/L ratio [<3.5] and 45 patients with higher N/L ratio [≥3.5]) who underwent PCI during January 2003 to August 2005. The primary endpoint was all‐cause mortality at a median follow‐up to 3.6 years.

Results

During the median ( ± SD) follow‐up period of 3.6 ± 1 years, there were a total of 48 deaths. The mortality rate was 10.4% in the group with a lower N/L ratio and 31.1% in the group with a higher N/L ratio (unadjusted p < 0.001). After adjustment for covariates with significant impact on mortality, N/L ratio was still a strong and independent predictor of long‐term mortality with a hazard ratio (HR) of 2.1 (95% confidence interval [CI]: 1.1–4; p = 0.02). N/L ratio was also found to be a strong and independent predictor of long‐term mortality even when analyzed as a categorical variable with 3 groups (HR of 0.39 for lower tertile compared to the upper tertile, 95% CI: 0.19–0.81; p = 0.012) and as a continuous variable (p = 0.002).

Conclusion

N/L ratio is a powerful independent predictor of long‐term mortality in African Americans undergoing PCI. Copyright © 2009 Wiley Periodicals, Inc.

Keywords: Neutrophil to lymphocyte ratio, African Americans, Percutaneous coronary intervention

Full Text

The Full Text of this article is available as a PDF (136.2 KB).

References

  • 1. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, et al.: Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005; 45: 1638–1643. [DOI] [PubMed] [Google Scholar]
  • 2. Núñez J, Núñez E, Bodí V, Sanchis J, Miñana G, et al.: Usefulness of the neutrophil to lymphocyte ratio in predicting long‐term mortality in ST segment elevation myocardial infarction. Am J Cardiol 2008; 101(6): 747–752. [DOI] [PubMed] [Google Scholar]
  • 3. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG et al.: Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long‐term mortality after percutaneous coronary intervention. Am J Cardiol 2006; 97: 993–996. [DOI] [PubMed] [Google Scholar]
  • 4. Hsieh MM, Everhart JE, Byrd‐Holt DD, Tisdale JF, Rodgers GP: Prevalence of neutropenia in the U.S. population: Age, sex, smoking status, and ethnic differences. Ann Intern Med 2007; 146(7): 486–492. [DOI] [PubMed] [Google Scholar]
  • 5. Marmur JD, Poludasu S, Agarwal A, Manjappa N, Cavusoglu E: High‐dose tirofiban administered as bolus‐only during percutaneous coronary intervention. J Invasive Cardiol 2008; 20(2): 53–58. [PubMed] [Google Scholar]
  • 6. Marmur JD, Poludasu S, Agarwal A, Vladutiu P, Feit A, et al.: Bolus‐only platelet glycoprotein IIb‐IIIa inhibition during percutaneous coronary intervention. J Invasive Cardiol 2006; 18(11): 521–526. [PubMed] [Google Scholar]
  • 7. Goodman DA, Goodman CB, Monk JS: Use of the neutrophil:lymphocyte ratio in the diagnosis of appendicitis. Am Surg 1995; 61(3): 257–259. [PubMed] [Google Scholar]
  • 8. Bialas M, Taran K, Gryszkiewicz M, Modzelewski B: [Evaluation of neutrophil‐lymphocyte ratio usefulness in the diagnosis of appendicitis]. Wiad Lek 2006; 59(9–10): 601–606. [PubMed] [Google Scholar]
  • 9. Curb JD, Ford CE, Pressel S, Palmer M, Babcock C, et al.: Ascertainment of vital status through the National Death Index and the Social Security Administration. Am J Epidemiol 1985; 121: 754–766. [DOI] [PubMed] [Google Scholar]
  • 10. Serrano CV Jr, Ramires JA, Venturinelli M, Arie S, D'Amico E, et al.: Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol 1997; 29: 1276–1283. [DOI] [PubMed] [Google Scholar]
  • 11. Spooner PM, Zipes DP: Sudden death predictors: An inflammatory association. Circulation 2002; 105: 2574–2576. [DOI] [PubMed] [Google Scholar]
  • 12. Cavusoglu E, Chopra V, Gupta A, Ruwende C, Yanamadala S, et al.: Usefulness of the white blood cell count as a predictor of angiographic findings in an unselected population referred for coronary angiography. Am J Cardiol 2006; 98(9): 1189–1193. [DOI] [PubMed] [Google Scholar]
  • 13. Rajagopal V, Gurm HS, Bhatt DL, Lincoff MA, Tcheng JE, et al.: Relation of an elevated white blood cell count after percutaneous coronary intervention to long‐term mortality. Am J Cardiol 2004; 94: 190–192. [DOI] [PubMed] [Google Scholar]
  • 14. Gurm HS, Bhatt DL, Gupta R, Eillis SG, Topol EJ, et al.: Preprocedural white blood cell count mortality after percutaneous coronary intervention. Am Heart J 2003; 146: 692–698. [DOI] [PubMed] [Google Scholar]
  • 15. Aghaji M, Nnabuko R, Uzuegbunam C, Oyeka IC: The relationship of white blood cell and platelet counts to cigarette smoking in adult Nigerians. Cent Afr J Med 1990; 36: 273–278. [PubMed] [Google Scholar]
  • 16. Gottlieb SS: Dead is dead—artificial definitions are no substitute. Lancet 1997; 349: 662–663. [DOI] [PubMed] [Google Scholar]
  • 17. Lauer MS, Blackstone EH, Young JB, Topol EJ: Cause of death in clinical research: Time for a reassessment? J Am Coll Cardiol 1999; 34: 618–620. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES